Oscar Health (OSCR) EBIT Margin (2020 - 2025)
Historic EBIT Margin for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to 19.6%.
- Oscar Health's EBIT Margin fell 187900.0% to 19.6% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.23%, marking a year-over-year decrease of 83300.0%. This contributed to the annual value of 3.39% for FY2025, which is 54100.0% down from last year.
- Per Oscar Health's latest filing, its EBIT Margin stood at 19.6% for Q4 2025, which was down 187900.0% from 4.33% recorded in Q3 2025.
- Over the past 5 years, Oscar Health's EBIT Margin peaked at 9.75% during Q1 2025, and registered a low of 47.68% during Q3 2021.
- Moreover, its 5-year median value for EBIT Margin was 7.55% (2022), whereas its average is 10.54%.
- As far as peak fluctuations go, Oscar Health's EBIT Margin surged by 915700bps in 2021, and later plummeted by -187900bps in 2025.
- Over the past 5 years, Oscar Health's EBIT Margin (Quarter) stood at 39.56% in 2021, then skyrocketed by 43bps to 22.36% in 2022, then dropped by -11bps to 24.83% in 2023, then soared by 97bps to 0.81% in 2024, then plummeted by -2333bps to 19.6% in 2025.
- Its EBIT Margin was 19.6% in Q4 2025, compared to 4.33% in Q3 2025 and 8.05% in Q2 2025.